SAN DIEGO, Oct. 25 – Incyte Genomics on Thursday announced it will jettison its custom genomics program and layoff roughly 400 employees as it restructures its business.

The discontinuation of the custom genomics product lines will lead Incyte to close its facilities in Fremont, Calif., and St. Louis, the company said. Details of the schedule for the shutdown were not disclosed.

The company also announced it was considering ending its internal therapeutic SNP discovery program, which is conducted in Cambridge, England, by the end of the year. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.